Cell-Easy logo

Cell-Easy

Your Cell-Therapy Specialized CDMO

35 employees · est. 2017 · Toulouse, France

VS
PBS Biotech logo

PBS Biotech

Next Generation Single-Use Bioreactors

100 employees · est. 2008 · Camarillo, United States

PBS Biotech is the older company (2017 vs 2008); PBS Biotech is the larger of the two.

Side-by-Side Comparison

Cell-Easy PBS Biotech
Founded
2017 2008 older
Headquarters
Toulouse, France Camarillo, United States
Employees
35 100 larger
Industry
Biotechnology, Health Care Biotechnology, Health Care, Medical Devices
Funding Stage
Undisclosed Series Unknown
Total Funding
$7.80M $32.00M
Funding Rounds
1 2
Services
Customized Process Development, GMP Manufacturing, Analytical Services Not tracked yet
Target Customers
Biotech Companies, Pharma Companies, Academic Institutions Not tracked yet
Taxonomy
Cell Therapy, ATMP, CDMO, GMP Manufacturing, Clinical Trials Support, Cell Culture, Biological Materials Sourcing, Allogeneic Approaches, Preclinical Drug Development, Quality Control, NK Cell, Stem Cell, T Cell, Clinical Drug Development Single-use Bioreactors, Bioprocess Solutions, Process Development Services, Cell Therapy Solutions, CGMP Production, USP Class VI Plastics, IPSCs, MSCs, Pluripotent Stem Cells, Mesenchymal Stem Cells, Stem Cells, Scale-up, 3D Cell Culture
Website
cell-easy.com pbsbiotech.com
Cell-Easy logo

About Cell-Easy

Cell-Easy is a France-based CDMO specialized in Cell Therapy. The company's mission is to accelerate Cell Therapy's path to market, with a focus on patient access. With expertise in cell culture across all cell types, Cell-Easy provides GMP development and manufacturing services for biotech, pharma,...

PBS Biotech logo

About PBS Biotech

PBS Biotech is a biotechnology startup founded in 2006 and headquartered in the United States. The company's slogan, "Next Generation Single-Use Bioreactors," accurately represents its focus on providing innovative, single-use bioreactor systems tailored for cultivating shear-sensitive cell types fo...

We will tell you when either one moves

BounceWatch watches Cell-Easy and PBS Biotech for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cell-Easy and PBS Biotech — by email.

Frequently Asked Questions

Cell-Easy — Your Cell-Therapy Specialized CDMO. PBS Biotech — Next Generation Single-Use Bioreactors. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cell-Easy has raised $7.80M while PBS Biotech has raised $32.00M.
Cell-Easy and PBS Biotech operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cell-Easy with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Cell-Easy on 7 Jun 2025, and PBS Biotech on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy